Insta
Indian pharmaceutical research (INDRANIL MUKHERJEE/AFP/Getty Images)
The $37 billion (Rs 2.15 lakh crore) Indian pharmaceutical sector is more robust than many of its global peers, American rating agency Moody's said on Friday (25 November).
"The Indian pharmaceutical companies, despite their smaller size, exhibit strong business profiles when compared to some of their global peers, underpinned by their good product and geographic diversity," Moody's Investor Service said in a statement from Singapore.
"When compared with their global counterparts, the Indian pharmaceutical companies have stronger financial profiles with low leverage and high coverage metrics," Moody's Vice President Kaustubh Chaubal said in the statement.
Moody’s associate analyst Diana Beketova said:
The Moody's report, titled ‘Indian Pharmaceutical Companies - A Deep Dive’, has been co-authored by Chaubal and Beketova.
According to it, the Indian generics market is the second-largest in the world, behind only the United States in terms of volume, although it forms only 1 per cent of the global pharmaceutical market by value. Though the Indian companies' R&D investments are low in absolute terms, they are large relative to their size - at 5 per cent to 8 per cent, Moody's said.
"These investments are likely to ramp up as companies start targeting complex generics, biosimilars and niche specialty drugs," it added.
The rating agency noted that over the last several years, the Indian pharmaceutical companies have grown their global presence and now operate in diverse regulated and unregulated markets.
With inputs from IANS
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest